SCHEMBL19615366

SCHEMBL19615366

CCOC(=O)c1c(Br)c(COc2cnc(-c3ccccc3OC)nc2)nn1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.38
EED O75530 3/20 0.37
ALOX5 P09917 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALKBH1 Q13686 1/20 0.37
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
SUZ12 Q15022 1/20 0.36
EZH2 Q15910 1/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PPARD Q03181 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PTGES O14684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19635285 0.82 MAPT (0.43) KMT2AMEN1POLBHPGDTSHR
SCHEMBL19635116 0.74 KMT2A (0.39) KMT2APOLBUSP2HPGDHSD17B10
SCHEMBL19635290 0.74 ALDH1A1 (0.41) KMT2AMEN1LMNAPKMHTT
SCHEMBL19635104 0.73 SMN1; SMN2 (0.42) KMT2AMEN1LMNAPOLBHPGD
SCHEMBL19615867 0.71 KMT2A (0.39) KMT2ALMNAUSP2HPGDTSHR
SCHEMBL19635177 0.71 KMT2A (0.41) KMT2ALMNAPOLBUSP2HPGD
SCHEMBL19618968 0.71 MRGPRX4 (0.47) KMT2AMEN1LMNAHPGDHTT
SCHEMBL19634877 0.70 HRH3 (0.41) ALOX5LMNAPOLBHPGDMAPT
SCHEMBL19615265 0.70 KMT2A (0.38) KMT2ALMNAUSP2HPGDHSD17B10
SCHEMBL19635143 0.70 MAPK13 (0.43) KMT2AMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492358-B1 Macrocyclic indole derivatives THE BROAD INSTITUTE, INC. (US) 2022-11-08 US disclosed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 EP disclosed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 EP disclosed
CN-109715632-B Macrocyclic indole derivatives 拜尔公开股份有限公司 2021-10-26 CN disclosed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 US disclosed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 US disclosed
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-03-19 US disclosed
EP-3458459-A1 MACROCYCLIC INDOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2019-03-27 EP disclosed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 WO disclosed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492358-B1 Macrocyclic indole derivatives CCND2, CCNT2, IDO1 VDR 657/4885EED 2837/4885ALOX5 1436/4885
US-10981932-B2 Macrocyclic indole derivatives CCND2, IDO1, CCNT2 VDR 459/4885EED 2405/4885ALOX5 1492/4885
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES CCND2, CCNA1, CCNT2 VDR 566/4885EED 2786/4885ALOX5 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.